While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to ...

Omeros’ Yartemlea gets US FDA approval to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy: Seattle Monday, December 29, 2025, 12:00 Hrs [IST] Omer ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

As enterprises modernize, the question is no longer whether to use SAP or non-SAP tools, but how to make them work together ...

Over the past two years, Generative AI (GenAI) has captured global attention, including here in Kenya, thanks to its ability to draft content, summarise reports ...

REDMOND, Wash. - Data I/O Corporation (NASDAQ:DAIO) announced Thursday changes to its Board of Directors with Edward Smith appointed as Chair of the Board and Steven Waszak joining as a new ...

BANGKOK, Nov. 19, 2025 /PRNewswire/ -- Delta, a global leader in power management and smart green solutions, and Siemens Smart Infrastructure have formalized a global partnership to deliver ...

Also called C3G, this rare kidney disease often affects children and young adults, but it can happen at any age. It has a major impact on a person’s health and life. C3G has two forms: dense deposit ...

– Single subcutaneous dose of ADX-038 achieved near-complete alternative pathway suppression for 6 months, supporting potent and selective CFB silencing – – Phase 2 studies are ongoing to assess the ...

Editor’s note: This is Part 1 of a two-part series on crime solutions from Katie Hill and Jens Ludwig of the University of Chicago Crime Lab. The overheated political moment we’re in has led people to ...

FORT DETRICK, Md. – An innovative study being undertaken by researchers at the U.S. Army Aeromedical Research Laboratory will provide vital data on the noise levels of small-arms fire, enabling the ...